Shreeram N. Agharkar
No más puestos en curso
Perfil
Shreeram N.
Agharkar worked as an Executive Director of Pharmaceutics R&D at Bristol Myers Squibb Co. He was also a Vice President & Deputy Head-Global Chemistry at Sanofi.
In addition, he served as a Director at Relmada Therapeutics, Inc. and was an Independent Director there from 2014 to 2016.
He was a Member of the American Association of Pharmaceutical Scientists, Drug Information Association, and Parenteral Drug Association.
Dr. Agharkar holds a graduate degree from The Trustees of Columbia University in The City of New York, a doctorate from the University of Kansas, and an undergraduate degree from the University of Mumbai.
Antiguos cargos conocidos de Shreeram N. Agharkar.
| Empresas | Cargo | Fin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/09/2016 |
| SANOFI | Corporate Officer/Principal | - |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | - |
| Parenteral Drug Association | Corporate Officer/Principal | - |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
Formación de Shreeram N. Agharkar.
| University of Mumbai | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| University of Kansas | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SANOFI | Health Technology |
| Empresas privadas | 5 |
|---|---|
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Camp Nine, Inc. operates as a clinical stage biopharmaceutical company. The company through its subsidiary Relmada Therapeutics, Inc. focused on developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Camp Nine was founded on May 31, 2012 and is headquartered in New York, NY. | Health Technology |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
| Parenteral Drug Association | |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
- Bolsa de valores
- Insiders
- Shreeram N. Agharkar